MIPS Value Pathways (MVPs)
The CY 2023 PFS Final Rule finalized five new MVPs and made modifications to the seven previously finalized MVPs, including the Advancing Rheumatology Patient Care MVP. The table below lists the measures and activities that are finalized within the Advancing Rheumatology Patient Care MVP.
Quality | Improvement Activities | Cost |
· Q111: Pneumococcal Vaccination Status for Older Adults
· Q130: Documentation of Current Medications in the Medical Record ad goes here:advert-1 ADVERTISEMENT SCROLL TO CONTINUE · Q134: Preventive Care and Screening: Screening for Depression and Follow-Up Plan · Q176: Tuberculosis Screening Prior to First Course Biologic Therapy ad goes here:advert-2 ADVERTISEMENT SCROLL TO CONTINUE · Q177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity · Q178: Rheumatoid Arthritis (RA): Functional Status Assessment · Q180: Rheumatoid Arthritis (RA): Glucocorticoid Management · ACR12: Disease Activity Measurements for Patients with PsA · ACR14: Gout Serum Urate Target · ACR15: Safe Hydroxychloroquine Dosing |
· IA_AHE_3: Promote use of patient-reported outcome tools
· IA_BE_1: Use of certified EHR to capture patient reported outcomes · IA_BE_4: Engagement of patients through implementation of improvements in patient portal · IA_BE_15: Engagement of patients, family and caregivers in developing a plan of care · IA_BMH_2: Tobacco use · IA_EPA_1: Provide 24/7 access to MIPS-eligible clinicians or groups who have real-time access to patient’s medical record · IA_EPA_2: Use of telehealth services that expand practice access · IA_PCMH: Electronic submission of patient-centered medical home accreditation · IA_PM_16: Implementation of medication management practice improvements · IA_PSPA_28: Completion of an accredited safety or quality improvement program |
Total Per Capita Cost (TPCC) |
FOUNDATIONAL LAYER | ||
Population Health Measures | Promoting Interoperability | |
· Q479: Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment System’s (MIPS) Eligible Clinician Groups
· Q484: Clinician and Clinician Group Risk standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions |
· Security Risk Analysis
· Safety Assurance Factors for EHR Resilience Guide (SAFER Guide) · e-Prescribing · Query of the Prescription Drug Monitoring Program (PDMP) · Provide Patients Electronic Access to Their Health Information · Support Electronic Referral Loops by Sending Health Information AND Support Electronic Referral Loops by Receiving and Reconciling Health Information OR · Health Information Exchange (HIE) Bi-Directional Exchange OR · Enabling Exchange under the Trusted Exchange Framework and Common Agreement (TEFCA) |